Clinical experience with intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of rectal balloon for prostate immobilization

Medical Dosimetry

Volumn 27, Issue 2, 2002, Pages 105-113

  Teh, Bin S ^a,b   Woo, Shiao Y ^a   Mai, Wei Yuan ^a   Mcgary, John E ^a   Carpenter, L Steven ^a   Lu, Hsin H ^a   Chiu, J Kam ^a   Vlachaki, Maria T ^a   Grant III, Walter H ^a   Butler, E Brian ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b MS 121 B   (United States)

Author keywords

Intensity modulated radiation therapy (IMRT); Prostate cancer; Rectal balloon

Indexed keywords

ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; DEVICE; HUMAN; IMMOBILIZATION; IMPLANT; INTENSITY MODULATED RADIATION THERAPY; POSTOPERATIVE PERIOD; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; PROSTATECTOMY; RADIATION DOSE; RADIATION INJURY; RECTAL BALLOON; TREATMENT OUTCOME; TREATMENT PLANNING; AGED; BALLOON DILATATION; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; MALE; MIDDLE AGED; PROSTATE TUMOR; RADIOGRAPHY; RECTUM; REVIEW;

AGED; AGED, 80 AND OVER; BALLOON DILATATION; HUMAN; IMMOBILIZATION; MALE; MIDDLE AGE; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RECTUM; TOMOGRAPHY, X-RAY COMPUTED; HUMANS; MIDDLE AGED;

EID: 0035987831     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-3947(02)00092-4     Document Type: Article

References (38)

1. Cancer statistics
2. The effect of dose on local control of prostate cancer
3. External beam radiotherapy dose response of prostate cancer
4. Does the 'Peacock' have anything to do with radiation therapy?
5. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate. Analysis of RTOG studies 7506 and 7706
6. Late radiation damage in prostate cancer patients treated with high dose external radiotherapy in relation to rectal dose
7. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomized trial
8. Acute morbidity reduction using 3D-CRT for prostate carcinoma: A randomized study
9. Intensity modulated radiation therapy
10. Intensity modulated radiation therapy: A new promising technology in radiation oncology
11. Immobilization devices for intensity-modulated radiation therapy (IMRT)
12. A system for planning and rotational delivery of intensity-modulated fields
13. SMART (Simultaneous Modulated Accelerated Radiation Therapy) boost - A new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy
14. A clinical evaluation of set-up errors for a prostate immobilization system
15. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder
16. Prostate motion during standard radiotherapy as assessed by fiducial markers
17. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning
18. Prostate movement: A function of shift and rotation
19. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI
20. Dose escalation with 3D conformal treatment: Five-year outcomes, treatment optimization, and future directions
21. Dose escalation with three-dimensional conformal radiation therapy affects outcome in prostate cancer
22. Preliminary report of toxicity following 3D conformal radiation therapy in prostate cancer on 3DOG/RTOG 94-06
23. Detailed mapping of prostate carcinoma foci
24. Prostate immobilization with rectal catheter/balloon for IMRT: A prostate motion study
25. A comparison of IMRT prostate treatment volumes and radical prostatectomy specimens
26. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-T2 prostate cancer
27. Fractionation and protraction for radiotherapy of prostate carcinoma
28. A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low
29. What is the alpha/beta ration for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy
30. Is the alpha/beta ratio for prostate cancer low?
31. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
32. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: Acute toxicity and dose volume analysis
33. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial
34. Intensity-modulated radiation therapy (IMRT) for prostate cancer: Rectal mucosal sparing by dosimetric effect of a rectal balloon
35. A systematic evaluation of air cavity dose perturbation in megavoltage-ray beams
36. Intensity-modulated radiation therapy (IMRT) following prostatectomy: More favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer
37. Consensus statement on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel
38. Three-dimensional conformal radiotherapy and escalation: Where do we stand?